Genetic and biological factors significantly influence the risk of metabolic disorders such as obesity, type 2 diabetes, and dyslipidemia. Advances in ‘omics’ technologies—genomics, epigenomics, transcriptomics, proteomics, metabolomics, and lipidomics—have greatly deepened our understanding of these complex conditions. At this second metabolic disease conference, global leaders will present the latest findings across these areas.
The conference will feature podium talks selected from submitted abstracts, along with posters and poster-pitch sessions to share research or gain feedback on ongoing work. Designed to foster knowledge exchange between scientists and clinicians in both basic and therapeutic research, the meeting offers many opportunities for collaboration and networking, with inclusive meals provided.
